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Background: Although identification of the target mRNAs of micro RNAs (miRNAs) is essential to understanding
their function, the low complementarity between miRNAs and their target mRNAs has complicated this process. In
this study, we sought to identify miRNAs which reduce the expression of the transcription factor Zeb-2, a transcriptional
repressor of E-cadherin which is known to be down regulated by members of the miR-200 family (miR-200a,b,c
miR-429, and miR-141).
Findings: We first used a computational target predicting system to identify 82 candidate miRNAs which bound
the 3′UTR region of the Zeb-2 mRNA. Of these 82 miRNAs, precursors for 51 were available in our miRNA precursor
library. Pre-miR™ Precursor Molecules for these 51 miRNAs were co-transfected into NIH3T3 cells with a luciferase
reporter vector containing the 3′UTR region of the Zeb-2 mRNA. Seven miRNAs (miR-141, mi-183, miR-200a,
miR-200b, miR-200c, miR-429 and miR-666-5p) were shown to down-regulate luciferase activity and Western
blotting analysis confirmed that Pre-miR™ Precursor Molecules for these seven miRNAs induced expression of
E-cadherin and miScript target protector against miR-183 and miR-666-5p abrogated this effect. Moreover, an
Anti-miR™ miRNA Inhibitor targeting miR-183 and miR-666-5p repressed expression of E-cadherin.
Conclusions: We have established a method to identify miRNAs that bind the 3′UTR region of the Zeb-2 mRNA
and that induce expression of E-cadherin, possibly by down-regulating the expression of Zeb-2. Our method may
be more widely applicable for identifying miRNAs that bind target mRNA 3′UTR regions and down-regulate the
expression of proteins encoded by these mRNAs.Background
MicroRNAs (miRNAs) are 22-nucleotide (nt) endogenous
non-coding RNAs that exhibit a high degree of structural
and functional conservation throughout different species.
miRNAs are initially synthesized as long primary tran-
scripts that are subsequently processed into −70-nt stem-
loop pre-microRNAs by Drosha endonucleasae [1] and
transported out of the nucleus by exportin 5 [2]. Dicer
then processes these pre-microRNA in the cytoplasm to
yield the −22-nt mature miRNAs [3]. Binding of miRNA
to target mRNAs with perfect or near perfect comple-
mentarity has been shown to induce mRNA degradation,
whereas imperfect complementarity reportedly induces* Correspondence: sooba-npr@umin.ac.jp
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reproduction in any medium, provided the ortranslational regression. In this context, 7–8 nt sequence
at the 5′ end of the miRNA sequence, known as the seed
sequence, is known to be critical for efficient targeting.
miRNAs have been implicated in regulating complex
physiological processes such as embryogenesis [4], organ
development [5], and oncogenesis [6,7], and we have re-
cently demonstrated their role in the pathology of kidney
diseases [8]. To date over 2000 miRNAs have been iden-
tified in human, although the functional roles of the vast
majority remain unknown.
Whereas identifying the target mRNAs of miRNAs is es-
sential to understanding their biological roles, this has
proven difficult due to the imperfect complementarily be-
tween miRNAs and their target mRNAs. cA recently de-
scribed method for identifying miRNA target mRNAs
using exogenously tagged Ago2 [9] has proven effective,
but has a complicated protocol and carries a high rate of
identification of artifactual mRNAs such as mitochondrial. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lysis to identify miRNAs targeting disease-related pro-
teins. Global expression profiling of cancer cell lines
overexpressing miR-16, for example, identified 27 can-
didate targets of this miRNA, of which three (MAP7,
PRDM44 and CDS2) were experimentally validated
[10]. In general however, such methods have proven un-
reliable for detection of disease-related miRNA target
genes. Here, we set out to establish a reliable method
for identifying miRNAs which down-regulate the ex-
pression of a specific target protein.
Many miRNAs have been shown to bind to the 3′UTR
region of their target mRNA. Previous studies have dem-
onstrated miRNA-mediated repression of the translation
of a luciferase reporter gene to which the 3′UTR coding
region of the target mRNA has been spliced [11]. In this
proof-of-principle study, we used a similar method to
identify miRNAs which down-regulated expression of
the E-box-binding zinc-finger transcription factor Zeb-2,
which has previously been shown to be repressed by
members of the miR-200 family (miR-200a,b,c miR-429,
and miR-141) [11-13].
We first established dual luciferase reporter vector
containing the 3′UTR coding region of Zeb-2 mRNA
spliced to the 3′ end of the luciferase coding region. We
then transfected cultured cells with this reporter vector
in 96-well plates and 48 hours later transfected cells with
a series of miRNA precursors. Luciferase activity was
assayed after 72 hours later to identify miRNAs which
bound the 3′UTR of Zeb-2 and subsequently reduced
luciferase expression. This method proved cumbersome
however, prompting us to use a computational target
predicting system to narrow down the number of
screened miRNAs to a figure (<100 miRNAs) that was
manageable, which a previous study had shown was
likely to yield true functional miRNAs (data not shown).
We anticipate that our new method will be valuable for
future characterization of miRNA function.
Materials and methods
Prediction of miRNAs by computational target predicting
system
To detect candidate miRNAs targeting Zeb2, we first eval-
uated a series of miRNA precursors. To narrow the
screened miRNAs to below 100 miRNAs, we used a com-
putational target predicting system (miRanda) containing
updated sequences for all known miRNAs [14-16]. Cutoff
scores for selection of candidate miRNAs were < −20.0 for
energy and >120 for binding.
ZEB2 3′-UTR luciferase reporter vector
We designed a dual luciferase reporter vector containing
the 3′UTR coding region of Zeb-2 mRNA spliced to the
3′end of the luciferase coding region. Firstly, the 3′-UTR for ZEB2 was PCR-amplified from mouse genomic
DNA. The PCR primers used to amplify the Zeb-2
3′-UTR were 5′-CAGTTCAGCCAAGACAGAGT-3′
(forward) and 5′-TTCGAGCATGGTCATTTTC-3′UTR
(reverse). The amplified 3′-UTRs was cloned down-
stream of the firefly luciferase coding region in the
pGL3-promoter luciferase reporter vector (Clontech).
Sequence analysis confirmed the accuracy of the PCR
procedure.
miRNA precursor library
In this study we used the Pre-miR™ miRNA Precursor
Library - Mouse V3 (Ambion co.).
Pre-miR™ miRNA Precursor Molecules are small,
chemically modified double-stranded RNA molecules
designed to mimic endogenous mature miRNAs. The
Pre-miR™ miRNA Precursor Library–Mouse V3 consists
of 379 miRNA mimics corresponding to 379 mouse ma-
ture miRNAs cataloged in version 9.2 of the miRBase
Sequence Database.
Cell culture
NIH3T3 and HK-2 cell lines were provided by the RIKEN
BRC through the National Bio-Resource Project of MEXT,
Japan. NIH3T3 cells were cultured in Dulbecco’s Modified
Eagle Medium (DMEM) containing 10% bovine serum.
HK-2 cells were grown in DMEM supplemented with 5%
fetal bovine serum. Cells were routinely cultured at 37°C
in a humidified atmosphere of 95% air-5% CO2.
Transfection and luciferase assays
NIH3T3 cells were seeded in 96 well plate (Sterilin UK).
24 hr later, 0.1 μg of reporter plasmid was transfected
using the Lipofectamine LTX system (Invitrogen), ac-
cording to the manufacturer’s protocols. To assess the
effect of miRNAs on reporter activity, 2.5 pmol of
synthetic Pre-miR™ miRNA Precursor Molecules and
Pre-miR™ miRNA Precursor Molecules-Negative Control
(Ambion co.) were transfected 48 hours later using the
Lipofectamine RNAiMax system (Invitrogen), according
to the manufacturer’s protocols. Cells were lysed after
24 hours in 40 μl passive lysis buffer (Promega). Mea-
surements were performed using the Promega luciferase
assay system and the GloMax 96 Microplate Lumin-
ometer (Promega). Each sample was measured in four
replicates. The luciferase activity of each lysate was nor-
malized to the luciferase activity of the Pre-miR™ Precur-
sor Molecules-Negative control.
Western blotting of E-cadherin
Western blotting analysis of E-cadherin was performed in
NIH3T3 cells. To investigate the effect of miRNAs on
Zeb-2 levels, NIH3T3 cells were transfected with 20 pmol/ml
Pre-miR™ Precursor Molecules and Anti-miR™ miRNA
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system (Invitrogen). To show a direct miRNA-mRNA
interaction at the predicted target sites, NIH3T3 cells
were transfected with 20 pmol/ml miRNA precursors and
300 pmol miScript target protector (Qiagen) against
miR-183 or miR-666-5p simultaneously. After 24 hours
the cell lysate was extracted and analysed by Western
blotting using a mouse monoclonal anti-E-cadherin
antibody (BD Bioscience). as previously described [8].
To confirm that the same amount of protein was investi-
gated, the expression of beta-actin was also investigated.
Effect of miRNAs on epithelial and mesenchymal
transition
To examine the effect of microRNAs to epithelial mesen-
chymal transition, we performed morphological observa-
tion and fluorescent staining of filamentous actin (F-actin)
in transfected cells. Normal human kidney HK-2 cells
(purchased from RIKEN) were transfected with Pre-miR™
miRNA Precursor Molecules for miR-183or miR-666-5p.
24 hours later 4 ng/ml TGF-beta was added and another
24 hours later, cells were observed under phase contrast
microscope. Cells were then fixed with 4% paraformalde-
hyde and incubated with Rhodamine-conjugated Phal-
loidin (CHEMICON) for 30 min, before observation
under a laser microscope.
Statistical analysis
All data are reported as mean ± SD. When comparisons
were made between two different groups, statistical sig-
nificance was determined using the Student’s t-test.
Findings
Results
Prediction of Zeb-2 mRNA 3’UTR-binding miRNAs
We identified in silico 82 candidate miRNAs (Table 1)
which were predicted to directly bind the 3′UTR of the
Zeb-2 mRNA and regulate expression of Zeb-2. These
candidates included all miRNAs, namely miR-141, miR-
200a,b,c and miR-429, previously shown to directly regu-
late Zeb-2.
Screening of miRNAs which can down-regulate the
expression of Zeb-2
Of these 82 miRNAs, Pre-miR™ miRNA Precursor Mole-
cules for 51which were available in our Pre-miR™ miRNA
Precursor Library, were co-transfected into NIH3T3 cells
along with a luciferase reporter vector containing the
3′UTR coding region of Zeb-2. Pre-miR™miRNA Precursor
Molecules for miR-141, miR-183, miR-200a, miR-200b,
miR-200c, miR-429 and miR-666-5p down-regulated lucif-
erase activity below 80% compared to control, (miR-141:
0.6 ± 0.106, miR183: 0.6 ± 0.106, miR-200a: 0.645 ± 0.031,miR-200b: 0.752 ± 0.163, miR-200c: 0.603 ± 0.03, miR-429:
0.633 ± 0.076) (Table 2).
Prediction of target sites of the identified miRNAs in the
Zeb-2 3′UTR
The miRanda computational target predicting system
identified potential target sites for the candidate miR-
NAs in the Zeb-2 3′UTR (Figure 1). miR-183, miR-200a,
miR-200b and miR-666-5p have at least one potential
target site, while miR-141 has two, miR-429 has three
and miR-200c has six.
Western blotting of E-cadherin
Zeb-2 has been shown to be a transcriptional repressor
of E-cadherin. Since we were unable to obtain an appro-
priate antibody for Zeb-2, we performed western blot-
ting of E-cadherin as a surrogate marker for Zeb-2
expression. Western blotting analysis showed that Pre-
Table 2 Relative luciferase activity of candidate miRNA
Control 1 ± 0.06
miR-124 1.15 ± 0.025
miR-136 1.17 ± 0.018
miR-138 0.952 ± 0.16
miR-141 0.6 ± 0.106
miR-152 0.919 ± 0.044
miR-155 0.934 ± 0.183
miR-183 0.769 ± 0.022
miR-200a 0.645 ± 0.031
miR-200b 0.752 ± 0.163
miR-200c 0.603 ± 0.03
miR-205 0.927 ± 0.017
miR-20a 0.963 ± 0.017
miR-22 0.954 ± 0.157
miR-23a 0.896 ± 0.038
miR-23b 0.904 ± 0.051
miR-27a 0.984 ± 0.156
miR-28 1.071 ± 0.038
miR-298 0.874 ± 0.08
miR-301b 1.032 ± 0.119
miR-320 0.964 ± 0.007
miR-324-3p 1.194 ± 0.031
miR-328 1.202 ± 0.016
miR-33 1.051 ± 0.125
miR-342-3p 0.854 ± 0.086
miR-34a 0.917 ± 0.043
miR-379 1.062 ± 0.140
miR-380-3p 0.958 ± 0.016
miR-429 0.633 ± 0.076
miR-448 0.931 ± 0.133
miR-449a 1.027 ± 0.023
miR-449b 1.022 ± 0.020
miR-452 0.826 ± 0.053
miR-469 1.096 ± 0.112
miR-470 0.948 ± 0.062
miR-471 0.814 ± 0.059
miR-541 0.985 ± 0.124
miR-547 0.934 ± 0.04
miR-666-5p 0.762 ± 0.022
miR-669c 0.965 ± 0.117
miR-674 0.993 ± 0.015
miR-680 1.148 ± 0.025
miR-686 1.176 ± 0.009
miR-691 1.018 ± 0.202
miR-693-3p 0.889 ± 0.005
Table 2 Relative luciferase activity of candidate miRNA
(Continued)
miR-697 0.979 ± 0.055
miR-698 1.002 ± 0.213
miR-706 1.037 ± 0.037
miR-708 0.983 ± 0.042
miR-712 0.821 ± 0.216
miR-742 0.976 ± 0.047
miR-96 0.927 ± 0.033
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ferred to above up-regulated expression of E-cadherin
(Figure 2a), most likely due to their down-regulation of
the expression of Zeb-2. Focusing on miR-183 and miR-
666-5p, we next examined whether Anti-miR™ miRNA
Inhibitor against miR-183 and miR-666-5p could down-
regulate the expression of E-cadherin. Western blotting
analysis confirmed that this was the case (Figure 2b).
miScript target protectors are modified RNA oligonucle-
otides complementary to specific target sites and which
do not bind other sequences [17]. Transfection of
custum-desigend miScript target protectors against the
predicted miR-183 and miR-666-5p target sites in the
Zeb-2 3′UTR abrogated the effect of the Pre-miR™ Precur-
sor Molecules for miR-183 and miR-666-5p (Figure 2c).
Cluster analysis of seven miRNAs
The miR-200 family of miRNAs has been mapped to
two separate clusters of less than 2000 bp each in the
mouse genome (Figure 3 upper panel) [3]. The first clus-
ter (Cluster 1) contains miR-200a, miR-200b and miR-
429 and is located in chromosome 4. The second cluster
(Cluster 2), containing miR-200c and miR-141, is located
in a 500-bp region of chromosome 6. The two remaining
miRNAs we identified, miR-183 and miR-666-5p, are lo-
cated on chromosome 6 (30119 K) and chromosome 12
(110955 K) respectively. The five miR-200 family miRNAs
located in the chromosome 4 and 6 clusters contain very
similar seed sequences (Figure 3 lower panel) which are not
shared with miR-183 and miR-666-5p.
The effect to epithelial and mesenchymal transition
Observation under phase contrast microscope revealed
that the addition of Transforming growth factor (TGF)-β
resulted in the appearance of the hallmarks of epithelial to
mesenchymal transition, including a change in mor-
phology from round compact shape to spindle shaped.
This was accompanied by a rearrangement of actin fila-
ments from a cortical to a stress-fiber pattern (Figure 3)
[10]. Transfection of Pre-miR™miRNA Precursor Molecules
for miR-183 and miR-666-5p inhibited the appearance
of these changes (Figure 4).
Figure 1 Schematic of putative detected miRNAs target sites for Zeb-2 3′UTR. Black boxes represent target sites for each miRNAs.
Figure 2 Western blotting of E-cadherin. (a) Western blotting of E-cadherin in NIH3T3 cells transfected with control miR or Pre-miR™. Precursor
Molecules individually. *p < 0.05, compared to cells transfected with Pre-miR™ miRNA Precursor Molecules-Negative Control. (b) Western blotting
of E-cadherin in NIH3T3 cells transfected with Anti-miR™ miRNA Inhibitor against miR-183 and miR-666-5p. *p < 0.05, compared to cells transfected with
Anti-miR™ miRNA Inhibitor-negative control. (c) Western blotting of E-cadherin in NIH3T3 cells transfected with Pre-miR™ Precursor Molecules for
miR-183 or miR-666-5p precursors and each Script Target Protector. *p < 0.05, compared to cells transfected with Pre-miR™ Precursor Molecules for
miR-183 and miScript target protector-negative control, **p < 0.05, compared to cells transfected with re-miR™ Precursor Molecules for miR-666-5p and
miScript target protector-negative control. The data are mean ± S.D. of triplicates and expression levels of E-cadherin were normalized to beta-actin
with further normalization to the negative control.
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Figure 3 Upper panel, schematic of chromosomal location of the detected miRNAs in the mouse genome. Lower panel, sequence
alignment of the detected miRNAs. Nucleotides 2–7, representing their seed sequences, are underlined.
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We report here a novel method of identifying miRNAs
which bind to the 3′UTR region of the Zeb 2 mRNA
and that up-regulate expression of E-cadherin. Several
reports have shown that members of the miR-200 family
(miR-200a,b,c, miR-141 and miR-429) inhibit epithelial
mesenchymal transition (EMT) through direct targeting
of ZEB1 and ZEB2, which encode transcriptional repres-
sors of E-cadherin in kidney tubular cells [4], breast can-
cer cells [5], and mammary epithelial cells [3]. Recent
reports have indicated that a double-negative feedback
loop between ZEB1, ZEB2 and miRNA-200 family mem-
bers regulates EMT in kidney tubular cells [18].
In this report, besides confirming down-regulation of
Zeb-2 by member of the miR-200 family, we have shown
that miR-183 and miR-666-5p can also down-regulateFigure 4 TGF-beta induced epithelial mesenchymal transition to HK-2
miR-183 and miR-666-5p. Phase contrast and Immunofluorescence staini
TGF-beta and, Pre-miR™ Precursor Molecules for miR-183 and miR-666-5p.Zeb-2. Using a novel screening method, we demonstrated
that while miR-23a, 298, 342-3p,452, 471, 693-3p, 712
down-regulated luciferase activity (above 80% compared
to control), they had no effect on E-cadherin levels, and
excluded them from further analysis.
While no target of miR-666-5p has been previously re-
ported, several studies have shown that miR-183 is up-
regulated in prostate carcinoma and breast cancer [19,20].
Given that EMT has been known to be associated with
tumorigenesis, it may be that up-regulation of miR-183 in-
hibits EMT in tumor tissue.
Our study contains another important new finding.
Many computational target prediction systems generate
large numbers of candidate miRNAs that potentially
down-regulate the expression of the proteins encoded by
these mRNAs. While we can not know in fact how manycells which was inhibited by Pre-miR™ Precursor Molecules for
ng of F-actin of HK-2 cells which was stimulated with 4 ng/ml
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based on our results, only about seven miRNAs can up-
regulate expression of E-cadherin, most likely due to their
down-regulation of the expression of Zeb-2. We have not
investigated all currently known miRNAs, however we can
infer that the number of miRNAs that can down-regulate
a single protein is limited.
Identifying the target mRNAs of miRNAs is essential to
understanding the cellular regulatory networks in which
miRNAs are involved, but due to the low complementarity
between miRNAs and their target mRNAs, only a few
mammalian target mRNAs have been identified. To ameli-
orate this situation, a variety of prediction algorithms,
such as miRanda [15,21], TargetScan [14,22,23], Pic Tar
[24], RNA22 [25], RNA hybrid [26], PITA [27], EiM Mo
[28] and DIANA [29], have been developed. These algo-
rithms use a spectrum of parameters, including binding
energy of the duplex structure, evolutionary conservation
of the target site and secondary structure of 3′UTR. Des-
pite this, they generate multiple false positive candidates
and, accordingly, experimental verification of predicted
miRNA-mRNA interactions must be performed. High-
throughput methods successfully used in validation ofFigure 5 Sequence alignment of microRNAs. Their seed sequences aremiRNA target sites, including microarray and proteomic
analysis, are based on measuring changes in the mRNA
and protein level in response to miRNA introduction [10].
However, they cannot identify microRNAs which down-
regulate a specific target protein and reporter assay such
as that used in this study are required to validate candidate
miRNAs routinely and with high specificity.
Our study contains one more important new finding.
Until now, we have been unable to determine the num-
ber of seed sequence matches needed for the binding
of miRNAs to target mRNA 3′UTR. In this reports, we
identified seven miRNAs which can directly regulate the
expression of Zeb-2. The number of seed sequence
matches for these miRNAs were eight (miR-200a, miR-
200c, miR-183, miR-429 and miR-666-5p) and seven
(miR-141 and miR-200b) (Figure 5), indicating that at
least seven seed sequence matches are desirable for a
miRNA to bind to a target mRNA 3′UTR. This informa-
tion is useful for the identification of miRNAs which can
directly regulate disease related proteins.
Immunoprecipitation of RNA induced silencing com-
plex (RISC)-associated mRNA requires a large amount of
starting material. Using a modification of this protocol,underlined.
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system for analyzing the mRNA content of RISC [2], and
identified mRNA targets of individual miRNAs. The RISC
complex however, contains multiple RNA species. For ex-
ample, Hayashida et al. showed that while almost all of the
cDNA recovered from RISC was miRNA (94%), the re-
mainder contained rRNA and tRNA clones (3% and 2%,
respectively) and cDNA clones (1%) with hits in genomic
DNA sequences. These facts indicate the difficulty of iden-
tifying target mRNAs in the RISC complex.
We set out in this study to develop a new method for
identifying target mRNAs for miRNAs. The originality of
our method is that it is based upon a functional endpoint,
namely down-regulation of a target protein. Using our
method we will be in a position to identify miRNAs which
can bind mRNA 3′UTR regions and down-regulate the
expression of the encoded proteins. In future, we hope
that the joint efforts of researchers all over the world will
enable us to establish a database of miRNAs which can
down-regulate the expression of specific protein targets.
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